Chai Discovery
Engineering better molecules using artificial intelligence.
Backed by
Raised $70M Series A on Aug 6, 2025
Chai has built an AI model that its founders claim can transform the process of designing molecules that bind to proteins and influence their function. The company aims to enable the creation of de novo antibodies and, ultimately, drugs.
Explore similar companies to Chai Discovery
Invert
Modern software for bioprocess data.
Sway
Seaweed as replacement for plastic.
Convoke
AI-native OS for drug development.
Science
A brighter tomorrow enabled by neural engineering.
Salt
AI for life sciences.
Cortical Labs
Lab-grown neurons with silicon chips.
Cradle
Design better proteins.
Manifold Bio
Tissue-targeted medicines, designed in vivo.
Colossal
The de-extinction company.